Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
€-23,383.69
% of Total Estimate Gain
-13.44%

Amplify Weight Loss Drug & Treatment ETF's Merck KGaA Holding Summary

As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held - shares of Merck KGaA(XTER:MRK), totaling N/A. This investment constitutes 0% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding Merck KGaA(XTER:MRK) stock.

The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 1 purchases of XTER:MRK, at an average price of €160.64, for a total of 1,083.00 shares. In addition, there have been 2 sales at an average price of €139.05 for 1,083.00 shares. Based on historical transaction data and XTER:MRK's current price of €109.35, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his XTER:MRK holdings is €-23,383.69, reflecting a -13.44% gain to date.

Amplify Weight Loss Drug & Treatment ETF XTER:MRK (€109.35) Holding Chart

Amplify Weight Loss Drug & Treatment ETF XTER:MRK (€109.35) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price €-/Share
Shares Sold 0 Average Price €-/Share
Current Price €0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1